Abstract: A system for driving a digital side mirror for vehicles, includes a moving case accommodating a camera for photographing the area surrounding the rear and the sides of a vehicle which is mounted in a housing and in a guide pipe mounted to a vehicle panel to be movable forwards and backwards thereof, wherein the camera accommodated in the moving case is controlled to photograph the area surrounding the rear and the sides of the vehicle even when the moving case is moved backwards and received in the housing and the guide pipe, facilitating a user to easily monitor the area surrounding the rear and the sides before turning on the vehicle or after turning off the vehicle.

Abstract: A semiconductor memory device comprising: a first semiconductor chip including an upper input/output pad, a second semiconductor chip including a lower input/output pad, and a substrate attachment film attaching the first and second semiconductor chips. The first and second semiconductor chips each include a first substrate including a first side facing the substrate attachment film and a second side, a mold structure including gate electrodes, a channel structure penetrating the mold structure and intersecting the gate electrodes, a second substrate including a third side facing the first side and a fourth side, a first circuit element on the third side of the second substrate, and a contact via penetrating the first substrate and connected to the first circuit element. The upper and lower input/output pads are on the second sides of the first and second semiconductor chip, respectively, and contact the contact vias of the first and second semiconductor chips.

Abstract: The present disclosure relates to a device for producing an aerogel blanket, and a method for producing an aerogel blanket. The device for producing an aerogel blanket according to present disclosure is a device for producing an aerogel blanket, including a supply part, which supplies a fiber containing sol, and a conveyor belt which moves the fiber supplied from the supply part, wherein the conveyor belt is provided in multiple levels to move the fiber while reversing the fiber, and a start time at which the conveyor belt reverses the fiber is before fluidity of the sol is completely lost.

Abstract: The present invention provides a seat-sliding apparatus for a vehicle. The seat-sliding apparatus includes a lower rail fixed to the vehicle, an upper rail, which is coupled to a seat and slides along the lower rail, a rail groove portion, which is formed in at least one surface of the lower rail and has therein a plurality of grooves, a tooth portion having teeth positioned between the grooves in the rail groove portion, a sloped portion, which is positioned at at least a portion of the rail groove portion and in which heights of the teeth of the tooth portion decrease toward a center of the rail groove portion from one end of the rail groove portion in a longitudinal direction, and a locking unit, which is positioned at the upper rail and is selectively engaged with the rail groove portion so as to hold the upper rail.

Abstract: A blood glucose control system according to an embodiment of the present invention includes a continuous blood glucose meter configured to continuously measuring blood glucose of a patient, a bio-signal sensor configured to acquire a bio-signal of the patient, a lifelog data collector configured to collect lifelog data of the patient, an insulin injection controller configured to determine an insulin injection amount and an injection rate based on one or more of blood glucose measurement information and blood glucose metabolism characteristic information received from the continuous blood glucose meter, the bio-signal acquired by the bio-signal sensor or a stress level of the patient indexed by the bio-signal, and the lifelog data collected by the lifelog data collector, and an insulin pump configured to inject insulin into a body of the patient according to the insulin injection amount and the injection rate determined by the insulin injection controller.

Abstract: The present disclosure relates to antibody-drug conjugates (ADCs) wherein one or more active agents are conjugated to an anti-CD19 antibody through a linker. The linker may comprise a unit that covalently links active agents to the antibody. The disclosure further relates to monoclonal antibodies and antigen binding fragments, variants, multimeric versions, or bispecifics thereof that specifically bind CD19, as well as methods of making and using these anti-CD19 antibodies and antigen-binding fragments thereof in a variety of therapeutic, diagnostic and prophylactic indications.

Abstract: A semiconductor device includes an active fin extending in a first direction on a substrate, a gate electrode intersecting the active fin and extending in a second direction, source/drain regions disposed on the active fin on both sides of the gate electrode, and a contact plug disposed on the source/drain regions. The contact plug has at least one side extending in the second direction which has a step portion having a step shape.

Abstract: The present invention relates to a graphene ink composition including charged chemically modified graphene, a graphene flake, a binder and a solvent, wherein an absolute value of the zeta potential of the charged chemically modified graphene is 25 mV or more.

Abstract: There is provided a semiconductor device in which a shape of an isolation layer in a structure in which upper nanosheets are stacked on lower nanosheets is controlled to improve reliability of the device. The semiconductor device includes an active pattern on a substrate and extending in a first direction, lower nanosheets spaced apart from each other in a second direction intersecting the first direction and on the active pattern, an isolation layer on the lower nanosheets and spaced apart from the lower nanosheets in the second direction, upper nanosheets spaced apart from each other in the second direction and on the isolation layer, and a gate electrode on the substrate and surrounding each of the lower nanosheets, the isolation layer, and the upper nanosheets, wherein a sidewall of the isolation layer has a curved shape.

Abstract: Proposed is a submodule of an MMC converter configured to stably supply power to a submodule controller controlling the submodule of an MMC converter. The submodule includes: an energy storage part storing electric energy therein; a plurality of switching elements connected in parallel to the energy storage part to have a shape of a bridge; a plurality of serially-connected resistors connected in parallel to the energy storage part; a plurality of DC-DC converters connected in parallel to a resistor of the plurality of resistors; a power switching part operating to select and output one voltage of voltages output from the plurality of DC-DC converters and a plurality of voltages input from outside; and a submodule controller operating with the voltage output by the power switching part so as to control switching operations of the plurality of switching elements.

Abstract: The present invention relates to a method for screening a cytokine having anticancer activity that inhibits the exosome secretion or suppresses the expression of PD-L1, wherein a vector composed of gene encoding cytokine, linker domain, and transmembrane domain transforms into cancer cells, and cytokine exhibiting anticancer activity can be selected, and thus the selected cytokine is provided as a new anticancer agent. In addition, the present invention relates to composition for preventing or treating cancer diseases, the composition comprising IL-15, selected using the above-mentioned screening technique, or expression promoter or activator thereof as an active ingredient. In the present invention, it was found that treating cancer cells with IL-15 suppresses exosome secretion and the expression of PD-L1, and it was also found that the anticancer effect is directly exhibited on the cancer cells. Therefore, IL-15 or expression promoter or activator can be effectively used to prevent or treat cancer diseases.

Abstract: The inventive concept provides a substrate treating apparatus. The substrate treating apparatus includes a chamber having a treating space therein; a support unit disposed within the treating space and configured to support a substrate; and a plasma generation unit configured to generate a plasma from a process gas supplied to the treating space; and wherein the plasma generation unit comprises: a bottom electrode member; and a top electrode member opposite to the bottom electrode member, wherein the top electrode member comprises: an electrode plate including an electrode; a first plate made of a different material from the electrode plate; and a second plate, and wherein the second plate, the electrode plate, and the first plate are stacked on one another.

Abstract: A dielectric pad and method of fabricating a dielectric pad for improving signal-to-noise ratio and image quality in MRI procedures. The dielectric pad includes a composition of TiO2, BaTiO3, or SiC mixed with a solvent to produce a flexible and stretchable pad for MRI use. The flexible and stretchable pad is configured to conform to various body shapes, to be wrap-able, and to be wearable for MR imaging procedures.

Abstract: The present invention provides an improved method of quantitative and/or qualitative analysis of a target molecule using nitrocellulose membrane (NCM). In particular, the present invention provides a porous nitrocellulose membrane that includes a surface and an organic nanostructured molecule that is non-covalently attached to the surface of NCM. The organic nanostructured molecule has a branched region that includes a plurality of terminal region (e.g., terminal end) moieties that are non-covalently attached or bound to a surface of the porous NCM. The organic nanostructured molecule also comprises a linear region that includes a covalently attached capture molecule that is adapted to selectively bind to a target molecule. The NCM of the invention provides an improved reproducibility, reliability, and selectivity compared an NCM in the absence of the organic nanostructured molecule.

Abstract: The present invention relates to a peptide targeting a toxin-antitoxin system of Mycobacterium tuberculosis and a use thereof. Specifically, the antibiotic peptide of the present invention inhibits the formation of a toxin-antitoxin complex of Mycobacterium tuberculosis without affecting an active site of the toxin, thereby inducing the death of Mycobacterium tuberculosis by means of a separated toxin. Therefore, the antibiotic peptide can be usefully used as an antibiotic composition against Mycobacterium tuberculosis.

Abstract: A semiconductor device may include a first active fin, a second active fin and a gate structure. The first active fin may extend in a first direction on a substrate and may include a first straight line extension portion, a second straight line extension portion, and a bent portion between the first and second straight line extension portions. The second active fin may extend in the first direction on the substrate. The gate structure may extend in a second direction perpendicular to the first direction on the substrate. The gate structure may cross one of the first and second straight line extension portions of the first active fin and may cross the second active fin.

Abstract: The present invention relates to a pyrrolobenzodiazepine derivative compound, a conjugate of the same with a ligand, and the use of the same. The pyrrolobenzodiazepine derivative compound is more stable in plasma, is stable even in circulation, and exhibits excellent efficacy. In particular, the conjugate of the pyrrolobenzodiazepine derivative compound with a ligand has a great advantage in that it is possible to target and specifically treat proliferative disease such as cancer, maximize drug efficacy, and minimize the expression of side effects since the conjugate more stably reaches the target cell and effectively exerts drug efficacy while toxicity is greatly reduced as a linker technology that allows drugs to be easily released within cancer cells and maximize drug efficacy is incorporated.

Abstract: The optical system disclosed in the embodiment includes first to fifth lenses sequentially disposed along an optical axis from an object side to an image side, each of the first to fifth lenses including an object-side surface and an image-side surface, a size of the effective aperture of the image-side surface of the first lens may be greater than the size of the effective aperture of the object-side surface of the first lens, and the thickness of the first lens may be smaller than the thickness of the second lens.

Abstract: Disclosed herein are a display device, and a method of testing a display device. The display device includes sub-pixels arranged along pixel columns, wire pads disposed in a non-display area and disposed on one side of the display area, fan-out lines extending in a first direction and connecting the sub-pixels with the wire pads, data lines extending in the first direction and connected to the fan-out lines, connection wires connecting the fan-out lines with the data lines, at least one of the connection wires including a first portion passing through the display area and extending in a second direction crossing the first direction; and a test unit disposed between the wire pads and the display area and electrically connected to the fan-out lines. The test unit applies a test voltage to the fan-out lines to check a short-circuit or an open-circuit in the fan-out lines.

Abstract: Disclosed are modularized garment manufacturing method and system for small quantity batch production of garments. Basic components constituting an ordered garment are generated by analyzing shape graphic data of the ordered garment. For each basic component, basic patterns are generated for each dimension of the ordered garment. The basic patterns are compared with reference garment patterns stored in a garment pattern database to determine a pattern category of each basic pattern. Based on the pattern category of the basic patterns and information on garment production lines currently in operation, subdivided work modules are determined for each basic pattern.